Literature DB >> 15856364

Osteogenesis imperfecta: a case with hand deformities.

Bengi Oz1, Nese Olmez, Asuman Memis.   

Abstract

In a 51-year-old woman with a history of fractures and dislocations after low intensity trauma in childhood, intensive blue sclera, short stature, and hearing loss, the diagnosis of osteogenesis imperfecta (OI) was suspected. She was referred to our clinic with hand deformities and left knee pain and stiffness. She had difficulty in walking and reported a history of immobilization for 6 months because of knee pain. She had bilateral flexion contracture of the elbows which occurred following dislocations of the elbows in childhood. She had Z deformity of the first phalanges, reducible swan-neck deformity of the third finger of the left and the second finger of the right hand, flexion contracture of the proximal interphalangeal joint of the fifth finger of the left hand, and syndactyly of the third and fourth fingers of the right hand. Flexion contractures of both knees were observed. Pes planus and short toes were the deformities of the feet. Acute phase reactants of the patient were normal. She had no history of arthritis or morning stiffness. Bone mineral density evaluated by dual-energy X-ray absorptiometry (DEXA) showed severe osteoporosis of the femur and lumbar vertebrae. She had radiographic evidence of healed fractures of the left fibula, the third metacarpal, and the fourth and fifth middle phalanges of the right hand. OI, affecting the type I collagen tissue of the sclera, skin, ligaments, and skeleton, presenting with ligament laxity resulting in subluxations and hand deformities may be misdiagnosed as hand deformities of rheumatoid arthritis.

Entities:  

Mesh:

Year:  2005        PMID: 15856364     DOI: 10.1007/s10067-005-1087-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Joint hypermobility and genetic collagen disorders: are they related?

Authors:  R Grahame
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

2.  How common is hearing impairment in osteogenesis imperfecta?

Authors:  C R Paterson; E A Monk; S J McAllion
Journal:  J Laryngol Otol       Date:  2001-04       Impact factor: 1.469

Review 3.  Osteogenesis imperfecta.

Authors:  Kathryn R McLean
Journal:  Neonatal Netw       Date:  2004 Mar-Apr

4.  Osteogenesis imperfecta and Achilles tendon rupture.

Authors:  C M Dent; G P Graham
Journal:  Injury       Date:  1991-05       Impact factor: 2.586

5.  Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.

Authors:  Frank Rauch; Horacio Plotkin; Leonid Zeitlin; Francis H Glorieux
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

6.  [Rupture in the palm of a flexor tendon in a young man with osteogenesis imperfecta].

Authors:  P Imbert; S Loy
Journal:  Chir Main       Date:  1999

7.  [Successful surgical treatment of aortic regurgitation due to annuloaortic ectasia and mitral regurgitation caused by tendon rupture in a case of osteogenesis imperfecta].

Authors:  Y Maekawa; T Hayashi; T Fujito; K Hoshi; H Kamishirado; Y Iwasaki; I Hisauchi; T Inoue; S Morooka
Journal:  J Cardiol       Date:  1997       Impact factor: 3.159

8.  Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.

Authors:  E Aström; S Söderhäll
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

Review 9.  Osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

10.  An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.

Authors:  J R Shapiro; M L Stover; V E Burn; M B McKinstry; A L Burshell; S D Chipman; D W Rowe
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.